Parkinson’s disease (PD) is among the most common chronic neurodegenerative conditions, affecting 1% of those over 60 years of age, and involves motor and non-motor impairments. Alterations in normal physiology may become apparent years – in some cases, 10–20 years – before established diagnostic criteria are met. Thus, better clinical outcomes may result when practitioners utilize nutritional and supplement interventions that support reductions in neuroinflammation and neurodegeneration as early as possible. PD is a devastating, progressive neurodegenerative condition that has both hereditary and environmental components to its pathogenesis, and early identification of risk factors and onset is critical. The purpose of this review is to highlight various nutrition and supplement interventions that may positively affect disease onset and progression, and that warrant further research.
Melatonin Supplementation in Children: A Narrative Review of Indications, Safety, and Potential Long-Term Effects
Small-scale studies suggest that long-term melatonin
supplementation safely and effectively treats sleep onset insomnia in children with
attention-deficit hyperactivity disorder (ADHD) and/or autism spectrum disorder
You can also access full issues of the Journal of Restorative Medicine here.